A clinical trial for individuals with Antiphospholipid Syndrome (APS).
Am I Eligible?
About DARE-APS
A study about the safety of daratumumab in patients with antiphospholipid syndrome (APS), and its effectiveness at reducing the antiphospholipid antibodies that cause APS.